Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Nuvalent, Inc. | Director | Class A Common Stock | 3.2K | $308K | $96.25 | Dec 5, 2024 | Direct |
Nuvalent, Inc. | Director | Stock Option (Right to Buy) | 4.85K | Dec 5, 2024 | Direct | ||
Epizyme, Inc. | President and CEO, Director | Common Stock, par value $0.0001 | 0 | $1.41 | Aug 12, 2022 | Direct | |
Epizyme, Inc. | President and CEO, Director | Stock Option (Right to Buy) | 0 | Aug 9, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
NUVL | Nuvalent, Inc. | Dec 5, 2024 | 2 | $0 | 4 | Dec 9, 2024 | Director |
NUVL | Nuvalent, Inc. | Dec 5, 2024 | 0 | $0 | 3 | Dec 9, 2024 | Director |
EPZM | Epizyme, Inc. | Aug 12, 2022 | 2 | $0 | 4 | Aug 16, 2022 | President and CEO, Director |
EPZM | Epizyme, Inc. | Aug 9, 2022 | 6 | $106K | 4 | Aug 11, 2022 | President and Chief Executive Officer, Director |
EPZM | Epizyme, Inc. | Mar 17, 2022 | 1 | $0 | 4 | Mar 21, 2022 | President and Chief Executive Officer, Director |
EPZM | Epizyme, Inc. | Feb 2, 2022 | 2 | $0 | 4 | Feb 4, 2022 | President and Chief Executive Officer, Director |
EPZM | Epizyme, Inc. | Aug 16, 2021 | 2 | $0 | 4 | Aug 18, 2021 | President and Chief Executive Officer, Director |
EPZM | Epizyme, Inc. | Jun 11, 2021 | 2 | $0 | 4 | Jun 15, 2021 | Director |